INSP: Inspire Medical Systems, Inc. Stock

by  •  • Comments Off on INSP: Inspire Medical Systems, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 6,998.98
Enterprise Value ($M) 6,813.44
Book Value ($M) 572.51
Book Value / Share 18.90
Price / Book 12.22
NCAV ($M) 489.44
NCAV / Share 16.15
Price / NCAV 14.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.04
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.04

Liquidity (mrq)
Quick Ratio 7.17
Current Ratio 7.60

Balance Sheet (mrq) ($M)
Current Assets 593.74
Assets 676.81
Liabilities 104.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 624.80
Operating Income -40.27
Net Income -21.15
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 24.65
Cash from Investing -294.82
Cash from Financing 13.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.93 -1.58
02-09 13G/A Fmr Llc 11.03 0.62
01-29 13G/A BlackRock Inc. 6.10 -15.71

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-09 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PUR
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Sep
2023-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Jun
2023-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Mar

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 91,469 604,213 15.14
2024-04-25 37,323 229,163 16.29
2024-04-24 40,227 255,686 15.73

(click for more detail)

Similar Companies
GKOS – Glaukos Corporation GMED – Globus Medical, Inc.
HAE – Haemonetics Corporation ITGR – Integer Holdings Corporation
MDT – Medtronic plc


Financial data and stock pages provided by
Fintel.io